window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Genomics and sequencing,Partnerships & Funding,Single Cell analysis,Technology and platforms

    SPT Labtech and Alithea Genomics partner to automate ultra sensitive single-cell RNA sequencing

    SPT Labtech has partnered with Alithea Genomics to automate single-cell [...]

    November 6, 2025
  • Biologics & Biosimilars,Biotech,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    Paris-based Tulyp Medical seeks FDA clearance following initial clinical use of perfusion device

    Tulyp Medical, a Paris-based medtech startup, has emerged from stealth [...]

    November 4, 2025
  • Biologics & Biosimilars,Biotech,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Technology and platforms

    AmacaThera signs exclusive global licensing agreement with Pacira Biosciences for up to $230 million

    AmacaThera has entered an exclusive worldwide licensing agreement with Pacira [...]

    November 4, 2025
  • Biotech,Drug Delivery & Formulation,Obesity,Pharmaceuticals and therapeutics,Research & Development,Supply Chain & Logistics,Technology and platforms

    Nanexa looks to get under the skin of GLP-1s and beyond

    Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

    November 4, 2025
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Veeva’s Sebastian Wurst on building the data foundation for enterprise AI

    The promise of AI in commercial biopharma is immense, with [...]

    November 7, 2025
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Most biopharma AI pilots fail to scale, survey warns, as leaders call for stronger data foundations

    A new survey of senior life sciences executives reveals that [...]

    October 25, 2025
  • Events and Conferences,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Technology and platforms

    CPHI Frankfurt 2025 announces 260 speakers and debuts new Leadership Summit

    Informa Markets has unveiled the 2025 speaker line-up for CPHI [...]

    October 21, 2025
  • Artificial Intelligence,Biotech,Chronic diseases,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Single Cell analysis,Technology and platforms

    Immunai signs $85 million AstraZeneca deal to advance inflammatory bowel disease target

    Immunai has signed an agreement worth up to $85 million [...]

    October 16, 2025
  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
Previous91011Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption
    Categories: Clinical Development, Clinical Trials, Data Management, Global health, Real world evidence
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top